| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 180 shares
@ $12.38, valued at
$2.2k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 695 shares
@ $22.91, valued at
$15.9k
|
|
| 06/02/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 504 shares
@ $23.21, valued at
$11.7k
|
|
| 05/25/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 10,000 shares
@ $22.14, valued at
$221.4k
Sold 10,000 shares
@ $22.33, valued at
$223.3k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
|
|
| 05/17/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 125 shares
@ $18.71, valued at
$2.3k
|
|
| 05/16/2023 |
4/A
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 2,093 shares
@ $20.03, valued at
$41.9k
Exercised 4,891 options to buy
@ $0 |
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 741 shares
@ $20.62, valued at
$15.3k
|
|
| 03/24/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 10,000 shares
@ $21.44, valued at
$214.4k
Sold 10,000 shares
@ $21.79, valued at
$217.9k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
|
|
| 03/09/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 415 shares
@ $22.95, valued at
$9.5k
|
|
| 03/03/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 2,086 shares
@ $22.75, valued at
$47.5k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 10,000 shares
@ $22.87, valued at
$228.7k
Sold 1,000 shares
@ $23.91, valued at
$23.9k
Sold 9,000 shares
@ $24.95, valued at
$224.6k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
|
|
| 01/10/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Granted 20,939 shares
@ $0
Granted 20,939 options to buy
@ $0 |
|
| 01/05/2023 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 9,500 shares
@ $17.72, valued at
$168.3k
Sold 500 shares
@ $18.81, valued at
$9.4k
Sold 500 shares
@ $17.71, valued at
$8.9k
Sold 9,500 shares
@ $18.49, valued at
$175.7k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
Exercised 10,000 options to buy
@ $2.06, valued at
$20.6k
|
|
| 12/30/2022 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 712 shares
@ $16.9, valued at
$12k
|
|
| 11/30/2022 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 436 shares
@ $19.93, valued at
$8.7k
|
|
| 11/14/2022 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 107 shares
@ $23.16, valued at
$2.5k
|
|
| 09/30/2022 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 657 shares
@ $23.02, valued at
$15.1k
|
|
| 09/01/2022 |
4
| Mathew Aby J. (EVP & Chief Scientific Officer) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 425 shares
@ $23.44, valued at
$10k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|